RE: Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-Based Cohort Study
Open Access
- 1 September 2020
- journal article
- letter
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 112 (9), 968-969
- https://doi.org/10.1093/jnci/djaa074
Abstract
Burkhard H Brandt, Ph.D, Natalia Bednarz-Knoll, Ph.D, Johannes Kleinheinz, MD, Andre Franke, Ph.D, Thomas Fillies, MD; RE: Oral leukoplakia and risk of progresFunding Information
- Deutsche Krebshilfe
- Fritz-Bender-Stiftung
This publication has 7 references indexed in Scilit:
- Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-Based Cohort StudyJNCI Journal of the National Cancer Institute, 2019
- Erlotinib and the Risk of Oral CancerJAMA Oncology, 2016
- Epidermal Growth Factor Receptor Expression and Gene Copy Number in the Risk of Oral CancerCancer Prevention Research, 2010
- Pharmacogenomic and Pharmacokinetic Determinants of Erlotinib ToxicityJournal of Clinical Oncology, 2008
- Mechanisms ofegfrGene Transcription Modulation: Relationship to Cancer Risk and Therapy ResponseClinical Cancer Research, 2006
- Aberrations of erbB-1 and erbB-2 oncogenes in non-dysplastic leukoplakias of the oral cavityBritish Journal of Oral and Maxillofacial Surgery, 1999
- Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer.1993